| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514441 Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents |
| 04/07/2009 | US7514435 Pyrrolotriazine kinase inhibitors |
| 04/07/2009 | US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | CA2511255C 2-piperidone derivatives as prostaglandin agonists |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2463815C Pharmaceutically acceptable alendronate salts in amorphous form |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2416624C Treatment of arthritis and compositions therefore |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/02/2009 | WO2009042854A1 Ion-channel regulator compositions and methods of using same |
| 04/02/2009 | WO2009042544A1 Quinone derivatives, pharmaceutical compositions, and uses thereof |
| 04/02/2009 | WO2009042542A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | WO2009042294A2 Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof |
| 04/02/2009 | WO2009042098A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 04/02/2009 | WO2009041798A1 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009041515A1 Bone resorption inhibitor and food, drink and drug containing the same |
| 04/02/2009 | WO2009041037A1 Drug for suppressing pathogen occurring in vivo |
| 04/02/2009 | WO2009041026A1 Cxcl10 production inhibitor |
| 04/02/2009 | WO2009040952A1 Drug containing benzophenone derivative or its salt |
| 04/02/2009 | WO2009040702A2 Pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | WO2009040268A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | WO2009039553A1 Benzothiazole compounds |
| 04/02/2009 | WO2009012425A3 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 04/02/2009 | WO2009003001A3 Preparation of risedronate sodium hemi-pentahydrate |
| 04/02/2009 | WO2006044657A3 Phosphate binder with reduced pill burden |
| 04/02/2009 | US20090088458 N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators |
| 04/02/2009 | US20090088438 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS |
| 04/02/2009 | US20090088429 Isoquinoline Derivatives |
| 04/02/2009 | US20090088404 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| 04/02/2009 | US20090087473 Osteoinductive bone graft material and manufacturing method |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | CA2709236A1 Pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | CA2700797A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 04/02/2009 | CA2700365A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | CA2700351A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | CA2700274A1 Quinone derivatives, pharmaceutical compositions, and uses thereof |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/02/2009 | CA2696113A1 Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042173A2 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 04/01/2009 | EP2040734A2 Antisecretory protein for use in the treatment of compartment syndrome |
| 04/01/2009 | EP2040705A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 04/01/2009 | EP2040696A2 Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 04/01/2009 | EP2040674A1 Cationic liposomal preparations for the treatment of rheumatoid arthritis |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1137666B9 Glp-1 analogues |
| 04/01/2009 | CN201213917Y Ion-induction traditional Chinese medicine plaster for treating cervical vertebra lumbar disease |
| 04/01/2009 | CN201213639Y Fine Hurong bed clothes |
| 04/01/2009 | CN101400669A Benzimidazole derivatives |
| 04/01/2009 | CN101400406A Compositions and methods of use for antibodies of Dickkopf-1 and/or -4 |
| 04/01/2009 | CN101397292A Method for producing strontium ranelate and its hydrates |
| 04/01/2009 | CN101396541A Traditional Chinese medicine for treating the cervical vertebra disease |
| 04/01/2009 | CN101396537A Chinese patent medicine capable of dredging collateral |
| 04/01/2009 | CN101396499A Foot treatment medicine for treating arthralgia leg |
| 04/01/2009 | CN101396497A Medicated pillow for treating cervical vertebra disease |
| 04/01/2009 | CN101396492A Quality control method for toxin ingredient, yunaconitine in Yuannan Hongyao capsule |
| 04/01/2009 | CN101396481A Medicine ointment for treating rheumatism |
| 04/01/2009 | CN101396467A Traditional Chinese medicine composition for treating livestock soft bone disease |
| 04/01/2009 | CN101396466A Cold medicine tea composition as medicine and food, preparation method and use thereof |
| 04/01/2009 | CN101396449A Manufacture method of quick muscles and tendons relaxing decoction |
| 04/01/2009 | CN101396448A Prescription for treating cervical vertebra disease |
| 04/01/2009 | CN101396437A Anti-gout drop pills of pure traditional Chinese medicine |
| 04/01/2009 | CN101396369A Pharmaceutical use of sophoricoside |
| 04/01/2009 | CN101396345A Sinomenine hydrochloride sustained-released injection and preparation method thereof |
| 04/01/2009 | CN101396120A Wind-dampness arthritis diet therapy soup |
| 04/01/2009 | CN100473402C Medicine for treating protrusion of intervetebral disc and cervical vertebra disease |
| 04/01/2009 | CN100473291C Food or pet food composition containing plant extract for bone health |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511052 N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl)carbonyloxy}phenylalanine; antiinflammatory agent; asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510847 Drug screening for compound having uricosuric regulating action by incubating a transformed cell expressing a recombinant protein with uric acid; and determining an uptake of uric acid; gout |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510733 Epimerdinoside a oral pharmaceutics containing the same and preparatory and determination methods |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2328368C Anti-inflammatory agents |
| 03/26/2009 | WO2009039341A2 Neoepitope detection of disease using protein arrays |